Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Vesicles | 4 | 2020 | 135 | 0.460 |
Why?
|
| RNA | 4 | 2019 | 1013 | 0.260 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 5 | 1993 | 173 | 0.200 |
Why?
|
| Immunoglobulin Variable Region | 2 | 1991 | 173 | 0.180 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2019 | 224 | 0.180 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 1989 | 1146 | 0.180 |
Why?
|
| Thymus Gland | 5 | 1993 | 294 | 0.170 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 2508 | 0.150 |
Why?
|
| Gene Ontology | 1 | 2016 | 80 | 0.140 |
Why?
|
| Cell Communication | 1 | 2019 | 509 | 0.140 |
Why?
|
| Epigenomics | 1 | 2016 | 266 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2020 | 1048 | 0.120 |
Why?
|
| Hypoxia | 2 | 2005 | 443 | 0.110 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1991 | 2 | 0.100 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1991 | 8 | 0.100 |
Why?
|
| Transcription, Genetic | 8 | 2004 | 3154 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 5159 | 0.100 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 67 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 4 | 1992 | 3203 | 0.090 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1989 | 14 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2020 | 2947 | 0.090 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 1989 | 78 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2020 | 1797 | 0.080 |
Why?
|
| DNA-Binding Proteins | 5 | 2004 | 4821 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2005 | 613 | 0.080 |
Why?
|
| Major Histocompatibility Complex | 1 | 1988 | 91 | 0.080 |
Why?
|
| Glioma | 1 | 2020 | 1963 | 0.080 |
Why?
|
| T-Lymphocytes | 4 | 2004 | 3869 | 0.080 |
Why?
|
| Base Sequence | 8 | 1994 | 4917 | 0.080 |
Why?
|
| RNA, Messenger | 7 | 2004 | 6150 | 0.080 |
Why?
|
| Molecular Sequence Data | 8 | 1994 | 6089 | 0.070 |
Why?
|
| Brain | 1 | 2020 | 4113 | 0.070 |
Why?
|
| Trans-Activators | 3 | 1997 | 1555 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 1992 | 1213 | 0.060 |
Why?
|
| DNA Restriction Enzymes | 1 | 2004 | 117 | 0.060 |
Why?
|
| Galactose | 1 | 2004 | 87 | 0.060 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 198 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 6 | 1994 | 2314 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 2483 | 0.060 |
Why?
|
| Muscles | 1 | 2004 | 416 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 343 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 869 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 557 | 0.050 |
Why?
|
| Transcription Factors | 5 | 2004 | 5270 | 0.050 |
Why?
|
| Mice | 12 | 2004 | 34495 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2004 | 3101 | 0.050 |
Why?
|
| DNA Repair | 2 | 2005 | 1872 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 621 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 182 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2004 | 1113 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 6009 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 41 | 0.040 |
Why?
|
| Animals | 14 | 2004 | 59536 | 0.040 |
Why?
|
| Circulating MicroRNA | 1 | 2019 | 25 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2000 | 246 | 0.040 |
Why?
|
| Body Fluids | 1 | 2019 | 125 | 0.040 |
Why?
|
| Zinc Fingers | 2 | 1997 | 205 | 0.040 |
Why?
|
| Placental Lactogen | 1 | 1997 | 7 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 3639 | 0.040 |
Why?
|
| Nervous System | 2 | 1995 | 165 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 1648 | 0.040 |
Why?
|
| Web Browser | 1 | 2016 | 17 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 1270 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 591 | 0.030 |
Why?
|
| Trophoblasts | 1 | 1997 | 138 | 0.030 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 1993 | 7 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 8873 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1995 | 41 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 651 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1992 | 130 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 201 | 0.030 |
Why?
|
| Gene Expression | 3 | 1999 | 3570 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 717 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 4053 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1995 | 292 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 1995 | 133 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 1997 | 1498 | 0.030 |
Why?
|
| Aging | 2 | 1992 | 1582 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 1547 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 825 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 745 | 0.030 |
Why?
|
| Algorithms | 1 | 2004 | 3890 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 354 | 0.030 |
Why?
|
| Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1992 | 3 | 0.030 |
Why?
|
| Databases, Factual | 1 | 1999 | 2218 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 15694 | 0.030 |
Why?
|
| Transfection | 3 | 2005 | 2944 | 0.030 |
Why?
|
| Software | 1 | 2019 | 1321 | 0.030 |
Why?
|
| Humans | 10 | 2020 | 261506 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2016 | 769 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1992 | 166 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1529 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1989 | 521 | 0.020 |
Why?
|
| Disease Progression | 2 | 2016 | 6682 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 3 | 1997 | 146 | 0.020 |
Why?
|
| Genes | 2 | 1989 | 491 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 227 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2016 | 1026 | 0.020 |
Why?
|
| Point Mutation | 1 | 1992 | 769 | 0.020 |
Why?
|
| Spleen | 2 | 1989 | 676 | 0.020 |
Why?
|
| Biotechnology | 1 | 1989 | 63 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2005 | 2084 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1995 | 998 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 1471 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 5047 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2000 | 5637 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1988 | 875 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 14551 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2016 | 2669 | 0.020 |
Why?
|
| GATA2 Transcription Factor | 2 | 1997 | 68 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 2864 | 0.020 |
Why?
|
| Liver | 1 | 1995 | 2961 | 0.020 |
Why?
|
| Kidney | 1 | 1994 | 2146 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2005 | 126 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 6295 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2004 | 55 | 0.020 |
Why?
|
| Cell Line | 2 | 1989 | 5114 | 0.020 |
Why?
|
| Luciferases | 1 | 2005 | 445 | 0.020 |
Why?
|
| Cell Separation | 1 | 2005 | 612 | 0.010 |
Why?
|
| In Situ Hybridization | 2 | 1997 | 1037 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2004 | 376 | 0.010 |
Why?
|
| Iron | 1 | 2004 | 376 | 0.010 |
Why?
|
| Rats | 2 | 2000 | 6086 | 0.010 |
Why?
|
| DNA | 1 | 1989 | 2693 | 0.010 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2000 | 34 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2000 | 54 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2000 | 59 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2000 | 224 | 0.010 |
Why?
|
| Female | 4 | 2019 | 141928 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 682 | 0.010 |
Why?
|
| Male | 5 | 2019 | 123000 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 2074 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 3033 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1999 | 195 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2000 | 351 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 703 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1997 | 69 | 0.010 |
Why?
|
| Prolactin | 1 | 1997 | 155 | 0.010 |
Why?
|
| Craniofacial Dysostosis | 1 | 1995 | 9 | 0.010 |
Why?
|
| Litter Size | 1 | 1995 | 26 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1999 | 1643 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1995 | 120 | 0.010 |
Why?
|
| Fetal Death | 1 | 1995 | 113 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 2063 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 1265 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1993 | 117 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2004 | 1833 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1997 | 650 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1997 | 747 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 3343 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 261 | 0.010 |
Why?
|
| Placenta | 1 | 1997 | 516 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 77950 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2000 | 1664 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1995 | 741 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 1995 | 341 | 0.010 |
Why?
|
| Gestational Age | 1 | 1995 | 1069 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 844 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 4971 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1995 | 1242 | 0.010 |
Why?
|
| Cell Movement | 1 | 1997 | 2466 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1989 | 293 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 5767 | 0.000 |
Why?
|
| Genotype | 1 | 1995 | 4109 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1994 | 4143 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 7548 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 1995 | 5710 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 4233 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1993 | 6942 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1989 | 2086 | 0.000 |
Why?
|
| Mutation | 1 | 1997 | 15179 | 0.000 |
Why?
|